Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002536 · ClinicalTrials.gov registry record · Phase 3
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
A Phase 3 study of Cervical Cancer, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
NCT00002536 is a Phase 3 study of Cervical Cancer that has completed, run by Gynecologic Oncology Group. The trial reports 20 study locations across 15 states.
The verdict
NCT00002536, a Phase 3 study of Cervical Cancer, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy drugs before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Randomized phase III trial to compare surgery with or without chemotherapy in treating patients who have stage IB cervical cancer.
Conditions Studied
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
- DRUG vincristine sulfate
- PROCEDURE surgical procedure
Study Locations (20)
California
- Southern California Permanante Medical Group - Bellflower
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- Community Hospital of Los Gatos - Los Gatos
- Chao Family Comprehensive Cancer Center - Orange
Illinois
- Rush-Presbyterian-St. Luke's Medical Center - Chicago
- University of Chicago Cancer Research Center - Chicago
Massachusetts
- Tufts University School of Medicine - Boston
- University of Massachusetts Memorial Medical Center - Worcester
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
Colorado
- University of Colorado Cancer Center - Denver
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Indiana
- Indiana University Cancer Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002536
The ClinicalTrials.gov registry entry for NCT00002536 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 4 interventions - of which cisplatin is the first listed.
NCT00002536 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00002536 about?
NCT00002536 is a clinical study titled "Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy drugs before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Randomized phase III trial to compare surgery with or without chem...
What is the current status of trial NCT00002536?
This trial is currently completed. It is a Phase 3 study. The study started on 1996-12.
What conditions does trial NCT00002536 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00002536?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION), vincristine sulfate (DRUG), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00002536?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002536 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
RECRUITING · Phase 3
-
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RECRUITING · Phase 3
-
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
COMPLETED · Phase 3
-
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
COMPLETED · Phase 3
-
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
COMPLETED · Phase 3
-
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.